News

 

Phase 1 unblinded results up to month 7 showed an excellent immunogenicity and safety profile confirming Valneva´s unique, single-shot vaccine...

Read more

The first “EMBO Fellow Mini-Symposium” will be held at the Vienna BioCenter on 4 and 5 June. The underlying idea is simple: EMBO fellows should meet...

Read more

After the successful introduction of the audio-series "gl’IMPses of research", the IMP presents a second episode featuring structural biologist David...

Read more

IMP scientists from the lab of Alexander Stark show why certain activators - enhancers or cofactor proteins - activate specific promoters. The...

Read more

HOOKIPA Pharma Inc. announced that it has achieved a further research milestone in its collaboration and license agreement with Gilead Sciences, Inc....

Read more

Repeated significant growth in IXIARO® revenues; Lyme disease and chikungunya programs advancing towards major data points; R&D investor day planned...

Read more

A new research award seeks to honour the World’s most outstanding PhD projects in molecular life sciences from the past year. The international...

Read more

Two-mentor scheme, opportunities for a two-month secondment and support by an inter-sectoral advisory board. The call for applications is open until...

Read more

Together with an international group of researchers, Youssef Belkhadir's lab at the GMI has identified a new class of bacterial molecules that trigger...

Read more

Max F. Perutz Laboratories group leader Andreas Bachmair has been promoted to full Professor of Genetics and Biochemistry by the University of Vienna....

Read more

Valneva will present on its Lyme disease and chikungunya vaccine candidates on April 16th, 2019 at the 19th World Vaccine Congress in Washington, D.C.

...

Read more

Structural biologists in the lab of IMP senior scientist Tim Clausen have characterised the structure of the protein arginine kinase McsB, a novel...

Read more